BONE BIOLOGICS CORP's ticker is and the CUSIP is 098070303. A total of 13 filers reported holding BONE BIOLOGICS CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3 | – | 17,260 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,500,000 | $387,750 | 0.34% |
| MFA WEALTH ADVISORS, LLC | 96,774 | $25,016 | 0.01% |
| Walleye Capital LLC | 806,159 | $208,392 | 0.00% |
| Warberg Asset Management LLC | 30,000 | $7,755 | 0.00% |
| WELLS FARGO & COMPANY/MN | 52 | $13 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 17,824 | $5 | 0.00% |
| UBS Group AG | 43,653 | $11,306 | 0.00% |
| Tower Research Capital LLC (TRC) | 8,311 | $2 | 0.00% |